A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053)

Inclusion Criteria: * Is a male between 40 and 95 years of age * Has osteoporosis * Has anatomy suitable for dual energy x-ray absorptiometry (DXA) scan of the lumbar spine and and hip * Is ambulatory Exclusion Criteria: * Is currently on oral bisphosphonates or other treatment for osteoporosis * Had previous hip fragility fracture and is a candidate for standard of care therapy * Has had a fragility fracture (vertebral or non-vertebral fractures indicating reduced bone strength) within 12 months * Has had more then one previous vertebral fracture * Has been diagnosed with metabolic bone disorder other than osteoporosis * Is Vitamin D deficient * Has a history of renal stones * Has active parathyroid disease * Has history of thyroid disease not well controlled by medication * Is diagnosed with secondary osteoporosis * Has a daily calcium intake of \<1,200 mg and is unwilling to take study prescribed supplements or increase dietary intake, such that his daily calcium intake is at least 1200 mg * Has a history of malignancy ≤5 years prior to signing informed consent * Has been diagnosed with hypogonadism due to causes that affect multiple organ and body systems